Effects of terazosin and tolterodine on ureteral stent related symptoms: A double-blind placebo-controlled randomized clinical trial

International Braz J Urol

Volumn 39, Issue 6, 2013, Pages 832-840

  Tehranchi, Ali ^a   Rezaei, Yousef ^a   Khalkhali, Hamidreza ^a   Rezaei, Mahdi ^b  

^a URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Adrenergic alpha antagonists; Cholinergic antagonists; Complications subheading ; Stents; Ureter

Indexed keywords

BENZHYDRYL DERIVATIVE; CRESOL; DRUG DERIVATIVE; PHENYLPROPANOLAMINE; PRAZOSIN; TERAZOSIN; TOLTERODINE; URINARY TRACT AGENT;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE REMOVAL; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FLANK PAIN; HUMAN; MALE; MIDDLE AGED; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; STENT; TIME; TREATMENT OUTCOME; URETER; VISUAL ANALOG SCALE; YOUNG ADULT;

ADOLESCENT; ADULT; BENZHYDRYL COMPOUNDS; CRESOLS; DEVICE REMOVAL; DOUBLE-BLIND METHOD; FEMALE; FLANK PAIN; HUMANS; MALE; MIDDLE AGED; PHENYLPROPANOLAMINE; PRAZOSIN; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; STENTS; TIME FACTORS; TREATMENT OUTCOME; URETER; UROLOGICAL AGENTS; VISUAL ANALOG SCALE; YOUNG ADULT;

EID: 84894037982     PISSN: 16775538     EISSN: 16776119     Source Type: Journal    
DOI: 10.1590/S1677-5538.IBJU.2013.06.09     Document Type: Article

References (27)

1. Chew BH, Knudsen BE, Denstedt JD: The use of stents in contemporary urology. Curr Opin Urol. 2004; 14: 111-5.
2. Haleblian G, Kijvikai K, de la Rosette J, Preminger G: Ureteral stenting and urinary stone management: a systematic review. J Urol. 2008; 179: 424-30.
3. Miyaoka R, Monga M: Ureteral stent discomfort: Etiology and management. Indian J Urol. 2009; 25: 455-60.
4. Joshi HB, Stainthorpe A, MacDonagh RP, Keeley FX Jr, Timoney AG, Barry MJ: Indwelling ureteral stents: evaluation of symptoms, quality of life and utility. J Urol. 2003; 169: 1065-9; discussion 1069.
5. Damiano R, Oliva A, Esposito C, De Sio M, Autorino R, D'Armiento M: Early and late complications of double pigtail ureteral stent. Urol Int. 2002; 69: 136-40.
6. Lee SJ, Yoo C, Oh CY, Lee YS, Cho ST, Lee SH, et al.: Stent Position Is More Important than α-Blockers or Anticholinergics for Stent-Related Lower Urinary Tract Symptoms after Ureteroscopic Ureterolithotomy: A Prospective Randomized Study. Korean J Urol. 2010; 51: 636-41.
7. Giannarini G, Keeley FX Jr, Valent F, Manassero F, Mogorovich A, Autorino R, et al.: Predictors of morbidity in patients with indwelling ureteric stents: results of a prospective study using the validated Ureteric Stent Symptoms Questionnaire. BJU Int. 2011; 107: 648-54.
8. Al-Kandari AM, Al-Shaiji TF, Shaaban H, Ibrahim HM, Elshebiny YH, Shokeir AA: Effects of proximal and distal ends of double-J ureteral stent position on postprocedural symptoms and quality of life: a randomized clinical trial. J Endourol. 2007; 21: 698-702.
9. Lingeman JE, Preminger GM, Goldfischer ER, Krambeck AE; Comfort Study Team: Assessing the impact of ureteral stent design on patient comfort. J Urol. 2009; 181: 2581-7.
10. Ecke TH, Bartel P, Hallmann S, Ruttloff J: Evaluation of symptoms and patients' comfort for JJ-ureteral stents with and without antireflux-membrane valve. Urology. 2010; 75: 212-6.
11. Kaplan SA, Roehrborn CG, Rovner ES, Carlsson M, Bavendam T, Guan Z: Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial. JAMA. 2006; 296: 2319-28. Erratum in: JAMA. 2007; 298: 1864.
12. Chapple C, Herschorn S, Abrams P, Sun F, Brodsky M, Guan Z: Tolterodine treatment improves storage symptoms suggestive of overactive bladder in men treated with alpha-blockers. Eur Urol. 2009; 56: 534-41.
13. Blake-James BT, Rashidian A, Ikeda Y, Emberton M: The role of anticholinergics in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a systematic review and meta-analysis. BJU Int. 2007; 99: 85-96.
14. Park SC, Jung SW, Lee JW, Rim JS: The effects of tolterodine extended release and alfuzosin for the treatment of double-j stent-related symptoms. J Endourol. 2009 ; 23: 1913-7.
15. Lim KT, Kim YT, Lee TY, Park SY: Effects of tamsulosin, solifenacin, and combination therapy for the treatment of ureteral stent related discomforts. Korean J Urol. 2011; 52: 485-8.
16. Beddingfield R, Pedro RN, Hinck B, Kreidberg C, Feia K, Monga M: Alfuzosin to relieve ureteral stent discomfort: a prospective, randomized, placebo controlled study. J Urol. 2009; 181: 170-6.
17. Mokhtari G, Shakiba M, Ghodsi S, Farzan A, Heidari Nejad S, Esmaeili S: Effect of terazosin on lower urinary tract symptoms and pain due to double-J stent: a double-blind placebocontrolled randomized clinical trial. Urol Int. 2011; 87: 19-22.
18. Deliveliotis C, Chrisofos M, Gougousis E, Papatsoris A, Dellis A, Varkarakis IM: Is there a role for alpha1-blockers in treating double-J stent-related symptoms? Urology. 2006; 67: 35-9.
19. Kuyumcuoglu U, Eryildirim B, Tuncer M, Faydaci G, Tarhan F, Ozgül A: Effectiveness of medical treatment in overcoming the ureteral double-J stent related symptoms. Can Urol Assoc J. 2012; 6: E234-7.
20. Davenport K, Kumar V, Collins J, Melotti R, Timoney AG, Keeley FX Jr: New ureteral stent design does not improve patient quality of life: a randomized, controlled trial. J Urol. 2011; 185: 175-8.
21. Lamb AD, Vowler SL, Johnston R, Dunn N, Wiseman OJ: Meta-analysis showing the beneficial effect of α-blockers on ureteric stent discomfort. BJU Int. 2011; 108: 1894-902.
22. Yakoubi R, Lemdani M, Monga M, Villers A, Koenig P: Is there a role for α-blockers in ureteral stent related symptoms? A systematic review and meta-analysis. J Urol. 2011; 186: 928-34.
23. Norris RD, Sur RL, Springhart WP, Marguet CG, Mathias BJ, Pietrow PK,et al.: A prospective, randomized, double-blinded placebo-controlled comparison of extended release oxybutynin versus phenazopyridine for the management of postoperative ureteral stent discomfort. Urology. 2008; 71: 792-5.
24. Rane A, Saleemi A, Cahill D, Sriprasad S, Shrotri N, Tiptaft R: Have stent-related symptoms anything to do with placement technique? J Endourol. 2001; 15: 741-5.
25. Damiano R, Autorino R, De Sio M, Cantiello F, Quarto G, Perdonà S, et al.: Does the size of ureteral stent impact urinary symptoms and quality of life? A prospective randomized study. Eur Urol. 2005; 48: 673-8.
26. Irani J, Siquier J, Pirès C, Lefebvre O, Doré B, Aubert J: Symptom characteristics and the development of tolerance with time in patients with indwelling double-pigtail ureteric stents. BJU Int. 1999; 84: 276-9.
27. Joshi HB, Newns N, Stainthorpe A, MacDonagh RP, Keeley FX Jr, Timoney AG: Ureteral stent symptom questionnaire: development and validation of a multidimensional quality of life measure. J Urol. 2003; 169: 1060-4.